{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:48:22Z","timestamp":1784566102284,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Carbapenem-resistant <jats:italic>Acinetobacter baumannii<\/jats:italic> (CRAB) is resistant to almost all antibiotics. Eravacycline, a newer treatment option, has the potential to treat CRAB infections, however, the mechanism by which CRAB isolates develop resistance to eravacycline has yet to be clarified. This study sought to investigate the features and mechanisms of eravacycline heteroresistance among CRAB clinical isolates. A total of 287 isolates were collected in China from 2020 to 2022. The minimum inhibitory concentration (MIC) of eravacycline and other clinically available agents against <jats:italic>A. baumannii<\/jats:italic> were determined using broth microdilution. The frequency of eravacycline heteroresistance was determined by population analysis profiling (PAP). Mutations and expression levels of resistance genes in heteroresistant isolates were determined by polymerase chain reaction (PCR) and quantitative real-time PCR (qRT-PCR), respectively. Antisense RNA silencing was used to validate the function of eravacycline heteroresistant candidate genes. Twenty-five eravacycline heteroresistant isolates (17.36%) were detected among 144 CRAB isolates with eravacycline MIC values \u22644 mg\/L while no eravacycline heteroresistant strains were detected in carbapenem-susceptible <jats:italic>A. baumannii<\/jats:italic> (CSAB) isolates. All eravacycline heteroresistant strains contained OXA-23 carbapenemase and the predominant multilocus sequence typing (MLST) was ST208 (72%). Cross-resistance was observed between eravacycline, tigecycline, and levofloxacin in the resistant subpopulations. The addition of efflux pump inhibitors significantly reduced the eravacycline MIC in resistant subpopulations and weakened the formation of eravacycline heteroresistance in CRAB isolates. The expression levels of <jats:italic>adeABC<\/jats:italic> and <jats:italic>adeRS<\/jats:italic> were significantly higher in resistant subpopulations than in eravacycline heteroresistant parental strains (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). An IS<jats:italic>Aba1<\/jats:italic> insertion in the <jats:italic>adeS<\/jats:italic> gene was identified in 40% (10\/25) of the resistant subpopulations. Decreasing the expression of <jats:italic>adeABC<\/jats:italic> or <jats:italic>adeRS<\/jats:italic> by antisense RNA silencing significantly inhibited eravacycline heteroresistance. In conclusion, this study identified the emergence of eravacycline heteroresistance in CRAB isolates in China, which is associated with high expression of AdeABC and AdeRS.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1356353","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:48:48Z","timestamp":1711514928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Emergence of eravacycline heteroresistance in carbapenem-resistant Acinetobacter baumannii isolates in China"],"prefix":"10.3389","volume":"14","author":[{"given":"Yi-tan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-xi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1128\/AAC.04809-14","article-title":"Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City","volume":"59","author":"Abdallah","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106644","article-title":"Population analysis profiling: is it still the gold standard for the determination of heteroresistance in carbapenemase-producing Enterobacteriaceae","volume":"60","author":"Abe","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.1038\/nmicrobiol.2016.53","article-title":"Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae","volume":"1","author":"Band","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1007726","DOI":"10.1371\/journal.ppat.1007726","article-title":"Heteroresistance: A cause of unexplained antibiotic treatment failure","volume":"15","author":"Band","year":"2019","journal-title":"PloS Pathog."},{"key":"B5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(21)00194-8","article-title":"Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens","volume":"21","author":"Choby","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in Acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/fmb.11.23","article-title":"Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance","volume":"6","author":"Durante-Mangoni","year":"2011","journal-title":"Future Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jac\/dkq027","article-title":"Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China","volume":"65","author":"Fu","year":"2010","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/jac\/dky083","article-title":"Diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii","volume":"73","author":"Gerson","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008965","article-title":"blaOXA-23-like and blaTEM rather than blaOXA-51-like contributed to a high level of carbapenem resistance in Acinetobacter baumannii strains from a teaching hospital in Xi'an, China","volume":"96","author":"Han","year":"2017","journal-title":"Med. (Baltimore)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251508","article-title":"Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients","volume":"16","author":"Hassan","year":"2021","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1080\/22221751.2021.1948804","article-title":"Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf","volume":"10","author":"Hua","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01717","article-title":"Multilocus sequence typing analysis of carbapenem-resistant acinetobacter baumannii in a chinese burns institute","volume":"7","author":"Huang","year":"2016","journal-title":"Front. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1021\/acsomega.7b00131","article-title":"Computational study reveals the molecular mechanism of the interaction between the efflux inhibitor PA\u03b2N and the adeB transporter from acinetobacter baumannii","volume":"2","author":"Jamshidi","year":"2017","journal-title":"ACS Omega"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.707435","article-title":"Epidemiological analysis of multidrug-resistant acinetobacter baumannii isolates in a tertiary hospital over a 12-year period in China","volume":"9","author":"Jiang","year":"2021","journal-title":"Front. Public Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0101021","DOI":"10.1128\/Spectrum.01010-21","article-title":"Tigecycline heteroresistance and resistance mechanism in clinical isolates of acinetobacter baumannii","volume":"9","author":"Jo","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15616\/BSL.2021.27.2.59","article-title":"Relationship between AdeABC Efflux pump genes and carbapenem in multidrug-resistant Acinetobacter baumannii","volume":"27","author":"Ju","year":"2021","journal-title":"Biomed. Sci. Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jgar.2017.08.002","article-title":"Colistin resistance among Blood culture isolates at tertiary Care centre Hungary","volume":"11","author":"Juh\u00e1sz","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01082-20","article-title":"Decreased incidence of methicillin-resistant staphylococcus aureus bacteremia in intensive care units: a 10-year clinical, microbiological, and genotypic analysis in a tertiary hospital","volume":"64","author":"Kim","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jgar.2022.05.020","article-title":"Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii","volume":"30","author":"Li","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104502","article-title":"Comparison of antimicrobial efficacy of eravacycline and tigecycline against clinical isolates of Streptococcus agalactiae in China: In vitro activity, heteroresistance, and cross-resistance","volume":"149","author":"Li","year":"2020","journal-title":"Microb. Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jmii.2021.08.012","article-title":"In vitro activity of cefiderocol, cefepime\/enmetazobactam, cefepime\/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020","volume":"55","author":"Liu","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1128\/JCM.00001-14","article-title":"Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method","volume":"52","author":"Marchaim","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3855\/jidc.17304","article-title":"Antibiotic resistance assessment and multi-drug efflux pumps of Enterococcus faecium isolated from clinical specimens","volume":"17","author":"Mirzaii","year":"2023","journal-title":"J. Infect. Dev. Ctries"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1128\/AAC.00366-16","article-title":"Antibacterial efficacy of eravacycline in vivo against gram-positive and gram-negative organisms","volume":"60","author":"Monogue","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/phar.2607","article-title":"Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: How viable are the current options","volume":"41","author":"O'Donnell","year":"2021","journal-title":"Pharmacotherapy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1586\/eri.13.14","article-title":"Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management","volume":"11","author":"Pogue","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.21037\/atm.2018.10.29","article-title":"New treatments of multidrug-resistant Gram-negative ventilator-associated pneumonia","volume":"6","author":"Poulakou","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/jac\/dkm058","article-title":"AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex","volume":"59","author":"Ruzin","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jhin.2017.04.005","article-title":"Emission of extensively-drug-resistant Acinetobacter baumannii from hospital settings to the natural environment","volume":"96","author":"Seruga Music","year":"2017","journal-title":"J. Hosp Infect."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104185","article-title":"Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC","volume":"80","author":"Shi","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms23010449","article-title":"Antibiotic heteroresistance in klebsiella pneumoniae","volume":"23","author":"Stojowska-Sw\u0119drzy\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049534","article-title":"A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii","volume":"7","author":"Sun","year":"2012","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1021\/acsinfecdis.1c00281","article-title":"A microbe-derived efflux pump inhibitor of the resistance-nodulation-cell division protein restores antibiotic susceptibility in Escherichia coli and Pseudomonas aeruginosa","volume":"8","author":"Tambat","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1089\/mdr.2019.0232","article-title":"Outbreak of multidrug-resistant acinetobacter baumannii ST208 producing OXA-23-like carbapenemase in a children's hospital in shanghai, China","volume":"27","author":"Wang","year":"2021","journal-title":"Microb. Drug Resist."},{"key":"B37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12866-020-01869-6","article-title":"Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na\/Pi cotransporter family protein in Staphylococcus aureus","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/aid2.13216","article-title":"Eravacycline for the treatment of complicated intra-abdominal infections","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Digestive Med."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00916","article-title":"Mechanism of eravacycline resistance in clinical enterococcus faecalis isolates from China","volume":"11","author":"Wen","year":"2020","journal-title":"Front. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"512.e511","DOI":"10.1016\/j.cmi.2018.06.012","article-title":"Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates","volume":"25","author":"Yang","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1128\/AAC.02556-12","article-title":"RND-type efflux pumps in multidrug-resistant clinical isolates of acinetobacter baumannii: major role for adeABC overexpression and adeRS mutations","volume":"57","author":"Yoon","year":"2013","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/jcm10051068","article-title":"An update on eight \"New\" Antibiotics against multidrug-resistant gram-negative bacteria","volume":"10","author":"Yusuf","year":"2021","journal-title":"J. Clin. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"B44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12866-018-1349-7","article-title":"Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Microbiol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00021","article-title":"Biofilm Formation in Klebsiella pneumoniae Bacteremia Strains Was Found to be Associated with CC23 and the Presence of wcaG","volume":"8","author":"Zheng","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41426-018-0141-y","article-title":"Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13756-020-00832-4","article-title":"The carbapenem resistance gene blaOXA-23 is disseminated by a conjugative plasmid containing the novel transposon Tn6681 in Acinetobacter johnsonii M19","volume":"9","author":"Zong","year":"2020","journal-title":"Antimicrobial Resistance Infection Control"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1356353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:48:52Z","timestamp":1711514932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1356353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":47,"alternative-id":["10.3389\/fcimb.2024.1356353"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1356353","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"article-number":"1356353"}}